Acknowledgement
Supported by : Golestan University of Medical Science
References
- Ahn SH, Kim do Y, Chang HY, et al. (2006) Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J Med Virol, 78, 1564-71. https://doi.org/10.1002/jmv.20739
- Ajuebor MN, Aspinall AI, Zhou F, et al (2005). Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J Immunol,174, 8027-37. https://doi.org/10.4049/jimmunol.174.12.8027
- Attar M, Azar SS, Shahbazi M. (2015) Interleukin-6-174 promoter polymorphism and susceptibility to hepatitis B virus infection as a risk factor for hepatocellular carcinoma in Iran. Asian Pac J Cancer Prev, 17, 2395-9.
- Azar SS, Mansoori M, Attar M, Shahbazi M. (2016) Tumor necrosis factor alpha-308 G/A single nucleotide polymorphism and susceptibility to hepatocellular carcinoma via hepatitis B infection. Asian Pac J Cancer Prev, 17, 3381-4.
- Bahmani MK, Khosravi A, Mobasser A, Ghezelsofla E. (2010) Seroprevalence of hepatitis B virus infection and vaccination compliance among health care workers in Fars Province, Iran. Arch Clin Infect Dis, 5, 45-50.
- Cheong JY, Cho SW, Chung SG, et al.( 2006) Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem Genet, 44, 246-55. https://doi.org/10.1007/s10528-006-9029-y
- Dean M, Carrington M, Winkler C, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter hemophilia cohort study, san francisco city cohort, ALIVE study. Science, 273, 1856-62. https://doi.org/10.1126/science.273.5283.1856
- Liang T, Chen E, Tang H (2013). Hepatitis B virus gene mutations and hepatocarcinogenesis. Asian Pac J Cancer Prev, 14, 4509-13. https://doi.org/10.7314/APJCP.2013.14.8.4509
- Lu Y, Bao J, Deng Y, et al (2015). Role of IL-18 gene promoter polymorphisms, serum IL-18 levels, and risk of hepatitis B virus-related liver disease in the Guangxi Zhuang population: a retrospective case-control study. Asian Pac J Cancer Prev, 16, 6019-26. https://doi.org/10.7314/APJCP.2015.16.14.6019
- Kakimi K, Guidotti LG, Koezuka Y, Chisari FV.(2000) Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med, 192, 921-30. https://doi.org/10.1084/jem.192.7.921
- Kazemi Arababadi M, Pourfathollah AA, et al.(2009) Detection of the CCR5-d32 Mutation in Patients Infected with Occult Hepatitis B. Zahedan J Res Med Sci, 11, 94-8.
- Khorramdelazad H, Hakimizadeh E, Hassanshahi G, et al.(2013) CCR5 Delta 32 mutation is not prevalent in Iranians with chronic HBV infection. J Med Virol, 85, 964-8. https://doi.org/10.1002/jmv.23510
- Murai M , Yoneyama H, Harada A, et al. (1999) Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest, 104, 49-57. https://doi.org/10.1172/JCI6642
- Nansen A, Christensen JP, Andreasen SO, et al. (2002)The role of CC chemokine receptor 5 in antiviral immunity. Blood, 99, 1237-45. https://doi.org/10.1182/blood.V99.4.1237
- Ng-Cashin J, Kuhns JJ, Burkett SE, et al.(2003) Host absence of CCR5 potentiates dendritic cell vaccination. J Immunol, 170, 4201-8. https://doi.org/10.4049/jimmunol.170.8.4201
- Rehermann B, Lau D, Hoofnagle JH, Chisari FV. (1996) Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest, 97, 1655-65. https://doi.org/10.1172/JCI118592
- Samson M, Libert F, Doranz BJ, et al.(1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382, 722-5. https://doi.org/10.1038/382722a0
- Shaban N, Salem H, ElsadanyM, et al (2016). Distribution of glutathione S-transferase omega gene polymorphism with different stages of HBV infection including hepatocellular carcinoma in the egyptian population. Asian Pac J Cancer Prev, 17, 2145-50. https://doi.org/10.7314/APJCP.2016.17.4.2145
- Shahbazi M, Ebadi H, Fathi D, et al.(2009) CCR5-delta 32 allele is associated with the risk of developing multiple sclerosis in the Iranian population. Cell Mol Neurobiol, 29, 1205-9. https://doi.org/10.1007/s10571-009-9415-1
- Sriprapun M, Chuaypen N, Khlaiphuengsin A, et al. (2016) Association of PINX1 but not TEP1 polymorphisms with progression to hepatocellular carcinoma in Thai patients with chronic hepatitis B virus infection. Asian Pac J Cancer Prev, 17, 2019-25. https://doi.org/10.7314/APJCP.2016.17.4.2019
- Suneetha PV, Sarin SK, Goyal A, et al (2006)Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. J Hepatol, 44, 856-63. https://doi.org/10.1016/j.jhep.2006.01.028
-
Tancredo as, pleasant, He Yan, et al. (2009)Association of
$CCR5-{\Delta}32$ polymorphism with HBV infection in special population of Guizhou Province. Shi Jie Hua Ren Xiao Hua Za Zhi, 17, 2317-9. - Thio CL, Astemborski J, Bashirova A, et al.(2007) Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence. J Virol, 81, 441-5. https://doi.org/10.1128/JVI.01897-06
-
Thio CL, Astemborski J, Thomas R, et al.( 2008) Interaction between RANTES promoter variant and
$CCR5{\Delta}32$ favors recovery from hepatitis B. J mmunol, 181, 7944-7. - Wanich N, Vilaichone R, Chotivitayatarakorn P, Siramolpiwat S (2016). High prevalence of hepatocellular carcinoma in patients with chronic hepatitis B infection in Thailand. Asian Pac J Cancer Prev, 17, 2857-60.
- Wong MM, Fish EN.(2003) Chemokines: attractive mediators of the immune response. Semin Immunol, 15, 5-14. https://doi.org/10.1016/S1044-5323(02)00123-9